How do enteroviruses almost completely evade the attentions of CD8+ T cells?

肠道病毒是如何几乎完全逃避CD8 T细胞的注意的?

基本信息

  • 批准号:
    8811097
  • 负责人:
  • 金额:
    $ 41.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-03-01 至 2018-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The immune system mounts strong CD8+ T cell responses to almost all acute virus infections. However, one virus genus - the enteroviruses - is a stark exception. These viruses can replicate to extremely high titers in vivo, and they induce CD4+ T cells and antibodies, yet these viruses almost completely avoid triggering na¿ve CD8+ T cells. Herein, using the CVB3 mouse model, we shall investigate the mechanism(s) by which enteroviruses achieve this remarkable feat. Antiviral CD8+ T cell responses are initiated when na¿ve CD8+ T cells are activated (or "primed") by contact with an MHC class I / epitope peptide complex on the surface of dendritic cells (DCs). Some viruses can infect DCs, in which case their proteins, being synthesized endogenously (i.e., within the DC) will enter the cell's MHC class I pathway, ultimately triggering CD8+ T cells; this process is called direct priming. However, there are at least two situations in which direct priming cannot occur. First, some viruses that infect DCs also encode proteins that very effectively inhibit MHC class I presentation, rendering the infected DC incapable of antigen presentation. Second, many viruses do not infect DCs. Nevertheless, in both of these cases, the host still mounts strong CD8+ T cell responses to most viruses. It is now known that viral proteins that have been released from infected cells can be taken up by a subset of uninfected DCs, allowing immunogenic proteins to be separated from MHC-inhibitory proteins; these DCs can present viral epitopes on MHC class I. This process is called cross-presentation and, if it results in the triggering of naive CD8+ T cells, it is termed cross-priming. This explains how the immune system can mount strong CD8+ T cell responses to almost all acute virus infections. Why can't it do so for CVB3? In Aim 1, I will investigate the possibility that CVB3 specifically inhibits the cross-priming pathway, preventing uninfected host DCs from capturing viral proteins. In addition, I have conceived of another explanation: that immunological information may be transferred not as protein, but as mRNA, and that the unique capacity of enteroviruses to evade CD8+ T cells results from the unusual coding strategy of these viruses. This mRNA transfer idea may be important beyond enteroviruses, because it also can explain the absence of CD8+ T cell responses to extracellular bacteria. Aims 2 & 3 test this new, and potentially-important, hypothesis. Aim 1. To assess the effect of CVB3 infection on cross-presentation / cross-priming. Aim 2. To ask if mRNA coding strategy explains how enteroviruses can almost completely evade naive CD8+ T cells, while most viruses induce strong CD8+ T cell responses. Aim 3. To determine if mRNA regulatory sequences explain why extracellular bacteria fail to induce strong CD8+ T cell responses.
描述(通过应用程序证明):免疫系统对几乎Alduste病毒感染的强烈CD8+ T细胞反应。抗体,但这些病毒几乎完全避免触发Na¿ VE CD8+ T细胞。我们将研究肠道病毒的机制。 VE CD8+ T细胞通过与树突状细胞表面上的MHC I /表位肽复合物接触(DC)会激活(或“启动”)。在细胞I途径中,在DC中,最终触发CD8+ T细胞; E至少两种直接启动的场所,某些感染了DCS ALSSO的病毒,这些病毒非常抑制了MHC类的蛋白不感染DC,但在这两种情况下,宿主仍然对大多数病毒的响应进行了强烈的CD8+ T细胞反应。蛋白质;这些DC可以在MHC类上呈现病毒表位。该过程称为交叉呈阳性,并且对CVB3的cD8+ T细胞反应几乎是对CVB3的。 CVB3特别抑制了从捕获病毒蛋白的交叉宣传途径。不寻常的编码是肠道的范围交叉呈现 /交叉播种。 T细胞反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J. Lindsay Whitton其他文献

J. Lindsay Whitton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J. Lindsay Whitton', 18)}}的其他基金

Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
  • 批准号:
    9225171
  • 财政年份:
    2015
  • 资助金额:
    $ 41.47万
  • 项目类别:
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
  • 批准号:
    8795589
  • 财政年份:
    2015
  • 资助金额:
    $ 41.47万
  • 项目类别:
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
  • 批准号:
    9027796
  • 财政年份:
    2015
  • 资助金额:
    $ 41.47万
  • 项目类别:
Analyzing the effects of type I interferons in the enterovirus-infected heart
分析 I 型干扰素对肠道病毒感染心脏的影响
  • 批准号:
    9198190
  • 财政年份:
    2015
  • 资助金额:
    $ 41.47万
  • 项目类别:
Analyzing the effects of type I interferons in the enterovirus-infected heart
分析 I 型干扰素对肠道病毒感染心脏的影响
  • 批准号:
    8997975
  • 财政年份:
    2015
  • 资助金额:
    $ 41.47万
  • 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
  • 批准号:
    8735569
  • 财政年份:
    2014
  • 资助金额:
    $ 41.47万
  • 项目类别:
How do enteroviruses almost completely evade the attentions of CD8+ T cells?
肠道病毒是如何几乎完全逃避CD8 T细胞的注意的?
  • 批准号:
    8630094
  • 财政年份:
    2014
  • 资助金额:
    $ 41.47万
  • 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
  • 批准号:
    8854024
  • 财政年份:
    2014
  • 资助金额:
    $ 41.47万
  • 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
  • 批准号:
    8894191
  • 财政年份:
    2014
  • 资助金额:
    $ 41.47万
  • 项目类别:
Cytotoxic T Cell Responses to Virus Infection
细胞毒性 T 细胞对病毒感染的反应
  • 批准号:
    8524204
  • 财政年份:
    2012
  • 资助金额:
    $ 41.47万
  • 项目类别:

相似国自然基金

母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
  • 批准号:
    82304205
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
P29单克隆抗体的3-羟基丁酰化修饰对其稳定性影响及提升抗泡型包虫病作用的研究
  • 批准号:
    82360402
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
肠道菌群影响PD-1抗体对潜伏HIV的作用及其机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
心衰患者中单克隆β1-肾上腺素受体自身抗体的筛选及其对受体构象影响的研究
  • 批准号:
    32271156
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
SARS-CoV-2 S2蛋白与肠道菌群交叉反应抗体的产生机制及其对新冠肺炎病程和疫苗效果的影响
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目

相似海外基金

Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
  • 批准号:
    10495114
  • 财政年份:
    2023
  • 资助金额:
    $ 41.47万
  • 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 41.47万
  • 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
  • 批准号:
    10727268
  • 财政年份:
    2023
  • 资助金额:
    $ 41.47万
  • 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
  • 批准号:
    10648346
  • 财政年份:
    2023
  • 资助金额:
    $ 41.47万
  • 项目类别:
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 41.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了